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ABSTRACT
Objective: To compare long-term outcome of children and young adults with arterial ischemic
stroke (AIS) from 2 large registries.
Methods: Prospective cohort study comparing functional and psychosocial long-term outcome
($2 years after AIS) in patients who had AIS during childhood (1 month–16 years) or young
adulthood (16.1–45 years) between January 2000 and December 2008, who consented to
follow-up. Data of children were collected prospectively in the Swiss Neuropediatric Stroke
Registry, young adults in the Bernese stroke database.
Results: Follow-up information was available in 95/116 children and 154/187 young adults.
Median follow-up of survivors was 6.9 years (interquartile range 4.7–9.4) and did not differ
between the groups (p 5 0.122). Long-term functional outcome was similar (p 5 0.896): 53
(56%) children and 84 (55%) young adults had a favorable outcome (modified Rankin Scale
0–1). Mortality in children was 14% (13/95) and in young adults 7% (11/154) (p 5 0.121) and
recurrence rate did not differ (p 5 0.759). Overall psychosocial impairment and quality of life did
not differ, except for more behavioral problems among children (13% vs 5%, p 5 0.040) and
more frequent reports of an impact of AIS on everyday life among adults (27% vs 64%,
p , 0.001). In a multivariate regression analysis, low Pediatric NIH Stroke Scale/NIH Stroke
Scale score was the most important predictor of favorable outcome (p , 0.001).
Conclusion: There were nomajor differences in long-term outcome after AIS in children and young
adults for mortality, disability, quality of life, psychological, or social variables. Neurology®
2015;84:1941–1947
GLOSSARY
AIS5 arterial ischemic stroke; CI5 confidence interval; IQR5 interquartile range;mRS5modified Rankin Scale;OR5 odds
ratio; QoL 5 quality of life; SNPSR 5 Swiss Neuropediatric Stroke Registry.
Outcome of arterial ischemic stroke (AIS) in children is considered more favorable than in adults
due to the better brain plasticity in children. However, several studies showed that more than
half of survivors of childhood AIS have long-term physical disabilities and cognitive impair-
ment.1–4 We previously compared short-term outcomes in children and young adults after
AIS: although stroke etiology and risk factors were different, stroke severity and clinical out-
comes were similar.5
Due to the ongoing maturation of the brain throughout childhood, only long-term follow-up
captures the full extent of a brain injury. Studies of long-term outcome in children with AIS are
mostly based on small single-center cohorts.6,7 One study analyzed the long-term impact of
childhood AIS on outcome in young adults: 63% of patients had mild to moderate deficits.8
Studies comparing long-term outcome after AIS in children and young adults are lacking.
The aim of this study was to compare functional and psychosocial outcomes and quality of
life (QoL) in children and young adults with AIS during long-term follow-up.
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METHODS This prospective cohort study is based on 2 regis-
tries: the Swiss Neuropediatric Stroke Registry (SNPSR) and the
Bernese stroke registry. Methods of both registries and study pop-
ulations were described previously.5 In the following description,
child refers to the age at AIS occurrence, not the age at follow-up.
Likewise, young adult refers to the age at AIS occurrence. In brief,
the SNPSR is a prospective multicenter pediatric cohort of all
patients with AIS or intracerebral venous thrombosis in
Switzerland. Research fellows contact all centers providing
specialist care for children with AIS monthly and all
neuropediatricians once a year to identify children with stroke.
Children from the SNPSR aged 1 month to 16 years who
experienced AIS between January 2000 and December 2008
were included in this study.
The Bernese stroke database is a large prospective registry
including patients with AIS or intracerebral venous thrombosis.
The University Hospital Bern (Inselspital) covers a catchment area
of about 1.5 million inhabitants and young adults with AIS are usu-
ally referred to the Inselspital. All patients from the Bernese stroke
registry aged 16–45 years with AIS between January 2000 and
December 2008 were included in this study. All patients included
in our previous short-term analysis who agreed to long-term follow-
up assessment were eligible for this study.
Long-term follow-up data were obtained by a telephone inter-
view with the patients or their proxies. For 1 child and 1 young
adult, follow-up was assessed during a clinical visit. In case of out-
dated contact details, we applied every legally and ethically possible
way to trace these patients. The interview was performed by neurol-
ogists, neuropediatricians in training, or research fellows using a
structured questionnaire (appendix e-1 on the Neurology® Web site
at Neurology.org). In brief, the questionnaire covers the following
domains: functional outcome (modified Rankin Scale [mRS] score);
recurrent cerebrovascular events; comorbidities; neurologic and psy-
chosocial sequelae such as seizures, fatigue, behavioral problems,
general state of health; treatment; occupational status; and impact
on everyday life. Overall QoL was assessed by a continuous scale and
on 5-point Likert scales. Additional complaints of patients not cov-
ered by the questionnaire were also recorded. Favorable outcome
was defined as mRS score 0–1, unfavorable as mRS score 2–6.
Statistical analysis. Quantitative data are expressed as median
and interquartile range (IQR). Data are reported in frequency
tables. Because some patients were lost during long-term follow-
up, we compared baseline characteristics in patients included in
the short-term study with those in the long-term study in order
to detect any selection bias. Missing data are indicated in the
tables and figures. Kolmogorov-Smirnov test was used to check
for normal distribution. Differences between children and young
adults were assessed using Fisher exact test (for comparison of
proportions), independent t test (for comparison of continuous
variables), and Mann-Whitney U test (for comparison of ordinal
variables). The Wilcoxon Paired Ranks Test was used to compare
short- and long-term outcome as expressed by the mRS. The
survival distribution of the 2 groups was compared with a log-
rank (Mantel-Cox) test. Possible predictors of outcome
(dependent variable 5 unfavorable outcome) with a regression
coefficient p , 0.2 in the binary logistic regression analysis were
included in the multivariate logistic regression analysis. A 2-sided
p value ,0.05 was considered statistically significant.
Standard protocol approvals, registrations, and patient
consents. The registries and long-term follow-up assessments
were approved by the local ethical committees and conducted
according to the Swiss law on research. Consent was obtained
from all participants.
RESULTS Information on long-term follow-up was
available for 95 of 116 children and for 154 of 187
young adults. Median follow-up of survivors was 6.9
years (IQR 4.7–9.4) and did not differ between
children and young adults (p 5 0.122). Follow-up
data in children were more often based on interviews
with proxies (51/62%) than in young adults (11/8%,
p, 0.001). Baseline characteristics and stroke etiology
are shown in table 1. There were no significant
differences in baseline characteristics, stroke workup,
and acute phase treatment in patients included in the
short-term study as compared to those in the long-term
study (table e-1). Median age of survivors at follow-up
was 15 years (IQR 9.3–19) in children and 45 years
(IQR 37.4–48.8) in adults. Five of 95 (6%) children
and 7/154 (5%) young adults had a recurrent
cerebrovascular event (p 5 0.759), with one fatality
in a young adult.
Long-term functional outcome according to mRS
was similar in both groups (p 5 0.896): 53 (56%)
children and 84 (55%) young adults had a favorable
outcome. Outcome from short-term (3–6 months) to
long-term follow-up did not differ among children
(p 5 0.176) or young adults (p 5 0.466) (figure 1).
Table 1 Baseline characteristics in children and young adults with arterial
ischemic stroke
Characteristics
Children
(n 5 95)
Young adults
(n 5 154) p
Female sex, n (%) 40/95 (42) 76/154 (49) 0.297
Traditional vascular risk factors,
n with condition/valid n (%)
Hypertension 3/63 (5) 31/152 (20) 0.004
Diabetes mellitus 0/94 3/153 (2) 0.290
Hyperlipidemia 9/56 (16) 45/149 (30) 0.050
Previous TIA 3/95 (3) 10/153 (7) 0.380
Previous stroke 0/95 4/153 (3) 0.301
Family history of stroke 9/87 (10) 23/133 (17) 0.175
Family history of CHD 11/87 (13) 15/132 (11) 0.832
PedNIHSS/NIHSS score on admission,
median (range)
5 (0–27) 6 (1–38) 0.350
Stroke etiology (TOAST), n (%) ,0.001
Large artery disease 0/95 5/154 (3)
Cardioembolic 16/95 (17) 57/154 (37)
Small artery disease 0/95 4/154 (3)
Other determined etiology 46/95 (48) 45/154 (29)
No cause identified 13/95 (14) 34/154 (22)
Incomplete investigations 3/95 (3) 7/154 (5)
More than one cause 17/95 (18) 2/154 (1)
Abbreviations: CHD 5 coronary heart disease; PedNIHSS 5 Pediatric NIH Stroke Scale;
NIHSS 5 NIH Stroke Scale; TOAST 5 Trial of Org 10172 in Acute Stroke Treatment.
A 2-sided probability (p) value ,0.05 was considered statistically significant.
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Mortality in children was 14% (13/95) vs 7%
in young adults (11/154) (p 5 0.121). Median sur-
vival time in children was 5 months (IQR 14 days–3
years), in adults 4 days (IQR 4 d–3 years) (p 5
0.072). The survival distribution of the 2 groups
did not differ (p5 0.178). Among patients who died
before short-term follow-up, the cause was stroke in
3/8 (38%) children and 6/8 (75%) young adults.5
Five children and 3 young adults died between
short-term and long-term follow-up. Causes of death
in these children were infection, leukemia, cardiac
disease (1 each), and unknown (2). Causes of death
in young adults who died between short-term and
long-term follow-up were cardiac disease, hepatorenal
syndrome, and metabolic disorder (1 each).
Functional outcome in survivors is shown in table 2.
Fifty-one of 82 (62%) children and 91/143 (64%)
young adults had at least one residual complaint (p5
0.886). Although overall language problems between
children and young adults did not differ significantly,
the language impairment was severe in just 6% of
children vs 27% of young adults. The severity of
residual symptoms did not change significantly
within the year prior to the interview in the majority
of patients. However, 23% of children and 14% of
young adults reported ongoing improvements.
Median follow-up duration was shorter in patients
reporting ongoing improvement (5 years) compared
with those reporting stable (7.2 years) or worsening
(7.5 years) residual symptoms (p 5 0.008).
The only difference in psychological and social out-
come was increased behavioral disturbances in children
(p5 0.040, table 3). Adults more commonly reported
an impact of AIS on everyday life (p , 0.001).
Quality of life did not differ between children and
young adults (p 5 0.204; figure 2). A majority in
both groups reported that they had enjoyed life in
the week prior to the interview (figure e-1A). More
than two thirds of children and young adults esti-
mated their QoL as equal to or better than their peers
(figure e-1B).
Therapy at long-term follow-up in stroke survivors
is shown in table e-1. Adults were more likely to
receive pharmacologic treatment, particularly aspirin,
clopidogrel, antihypertensive agents, or statins. How-
ever, there were no differences in oral anticoagulants,
antidiabetics, or antidepressants. Children more often
had rehabilitation therapies such as physiotherapy,
occupational therapy, or speech and language
therapy.
In a multivariate logistic regression analysis, a low
pediatric NIH Stroke Scale/NIH Stroke Scale score
on admission was an independent predictor of favor-
able outcome in both children (p5 0.003, odds ratio
Figure 1 Short-term and long-term outcome in children and young adults, assessed with the modified Rankin Scale
One child (1%) and 3 young adults (2%) had long-term follow-up (FU) only. mRS 5 modified Rankin Scale. pa 5 Mann-Whitney U test, 2-sided significance;
pb 5 Wilcoxon paired rank test, 2-sided significance.
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[OR] 0.846, 95% confidence interval [CI] 0.757–
0.945) and young adults (p , 0.001, OR 0.817,
95% CI 0.748–0.893). Other independent variables,
namely age, sex, stroke etiology, risk factors such
as hypertension, hypercholesterolemia, diabetes, pre-
vious TIA, or stroke, and most acute phase and sec-
ondary preventive treatment did not predict
outcome. However, the absence of acute phase treat-
ment with heparin in children (p 5 0.025, OR
0.317, 95% CI 0.116–0.863) and with clopidogrel
in adults (p 5 0.004, OR 0.039, 95% CI 0.004–
0.348) were additional predictors of favorable
outcome.
DISCUSSION This comparison of long-term clinical
outcome after AIS in children and young adults
describes 3 major findings: (1) There were no major
differences in long-term functional outcomes, for
mortality or disability, and recurrence rates were
similar. (2) Overall psychosocial impairment did
not differ between patients who experienced AIS
during childhood vs early adulthood, although
children had more behavioral problems and adults
more commonly reported a negative impact of AIS
on everyday life. (3) QoL was similar in patients
who experienced AIS during childhood vs early
adulthood.
Mortality in children (14%) and young adults
(7%) did not reach a statistically significant difference
at long-term follow-up. Long-term follow-up reports
on mortality in children after AIS are scarce. Previous
studies reported mortality rates of 2%–11.5% in chil-
dren and 3%–27% in young adults.7,9–15 However,
there are no population-based studies with long-term
follow-up in children. In our short-term study,
median survival time in children was 5 months, vs a
median of 4 days in young adults (p 5 0.072).5 This
difference was mainly caused by the fact that 6 of 11
young adults died due to stroke, vs 3 of 13 children.
An underlying disease that provoked the stroke usu-
ally caused deaths among children.
Five percent of children and 6% of young adults
had a recurrent ischemic cerebrovascular event.
Recurrence rates in children were lower than in most
previous reports on childhood AIS, ranging from
6.6% to 38% after follow-up periods from 5 months
to 5 years.8,16–19 Low recurrence rates in our child
cohort can be explained by few patients with under-
lying diseases that carry a high risk of recurrence, such
as moyamoya and sickle-cell disease.
In our previous study on short-term outcome in
children and young adults, we found no differences
in functional outcome. There is a general assumption
that long-term outcome in children after acquired
brain disease is better than in adults due to the
increased plasticity of the immature brain. However,
long-term functional outcome in our study was sim-
ilar: 56% of children and 55% of young adults had a
good outcome after a median follow-up duration of
6.9 years. There were no differences in outcome from
short-term to long-term follow-up among children or
young adults.
The mRS is a crude estimate of functional out-
come and was not designed for use in children.
Therefore, we assessed additional items to capture
slight deficits that were not detected by the mRS.
There were no significant differences regarding motor
deficits, balance problems, visual disturbances, seiz-
ures, or headache. One fifth of children and one
fourth of young adults had language impairments,
with no significant difference overall. However,
among patients with language impairment, only 6%
of children had a severe deficit, vs 27% of young
adults. The ongoing lateralization process in children
might explain this: cognitive functions in the language
domain emerge from an initially bilateral pattern
towards more specialized unilateral networks.20–22
In contrast to young adults, children have wider net-
works to reactivate for compensation after damage of
the areas responsible for language. Lateralization dur-
ing maturation and reactivation of networks are not
only observed in language domains, but also in other
functions such as visuospatial tasks; however, these
domains were not tested in our study.22,23 In contrast
to language and cognition, motor function lateralizes
Table 2 Functional outcome in stroke survivors
Characteristics
Children (n 5 82),
n with condition/
valid n (%)
Young adults
(n 5 143), n with
condition/valid n (%) p
Paresis 45/82 (55) 66/139 (48) 0.330
Mild 22 (49) 23 (35)
Moderate 16 (35) 30 (45)
Severe 7 (16) 13 (20)
Impaired balance 8/82 (10) 15/139 (11) 1.000
Visual disturbances 4/82 (5) 11/139 (8) 0.581
Language difficulties 17/82 (21) 37/143 (26) 0.421
Mild 10 (59) 21 (57)
Moderate 6 (35) 6 (16)
Severe 1 (6) 10 (27)
Seizures 12/82 (15) 15/139 (11) 0.403
Active seizures 1 (8) 1 (7) 1.000
Headache 3/82 (4) 10/139 (7) 0.381
Evolution of residual symptoms
within the last 12 months
0.114
Better 19/82 (23) 20/139 (14)
Same 61/82 (75) 115/139 (83)
Worse 2/82 (2) 4/139 (3)
A 2-sided p value ,0.05 was considered statistically significant.
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earlier, and therefore reorganization processes might
be similar in adults and children.
Initial stroke severity was the main predictor of
outcome in both groups, which has not been previ-
ously described during long-term follow-up in
children. Further predictors of outcome were the
absence of heparin in children and the absence of
clopidogrel in young adults. Both drugs are mainly
given to severely affected patients or patients with
multiple risk factors, and therefore probably reflect
the underlying pathology.
Comparison of functional outcome after AIS, par-
ticularly in children, is hampered by the heterogeneity
in study designs, populations, timing, and use of differ-
ent outcome scales. In studies on outcome in child-
hood stroke, particularly the wide range of outcome
scores, which are often not validated, hinders the com-
parison of results. In young adults, the definition of
young ranges from 16 to 45 years, as in our study,
to 18 to 55 years. Moreover, the few studies reporting
long-term outcome in young adults are either based on
a retrospective selection of patients,24 which carries the
risk of a selection bias, or use other outcome measures
than the mRS.11 In the prospective Follow-Up of
Transient Ischemic Attack and Stroke Patients and
Unelucidated Risk Factor Evaluation (FUTURE)
study, the detailed comparison of the distribution of
mRS scores reveals results that are similar to ours (mRS
0–1 in 46%, according to figure C in the cited article,
compared to 55% in our study).25
Little is known about psychosocial disturbances after
AIS in young patients, particularly in children.26 How-
ever, for stroke survivors, psychosocial aspects may be
more relevant than pure functional outcomes. Therefore
we assessed items capturing the impact of stroke on
everyday life. There were no differences in schooling
or occupation, residence, or overall psychological out-
come. However, children more often had behavioral
problems and adults more commonly reported an
impact of AIS on everyday life. The higher rate of behav-
ioral disturbances in children was age-independent and
was not specific for teenagers. Given the different life
circumstances and expectations that define a normal life,
young adults may be more likely to notice even slight
impairments. Behavioral problems in children might
reflect impairments in everyday life, whereas adults
may have other means of coping, such as verbalizing
their difficulties in discussions with relatives or health
care providers. Despite these differences, general state of
health was rated similarly.
Although no formal scales have been validated for
both children and young adults, we tried to capture
the impact of AIS on QoL in children and young
adults. Median QoL on a continuous scale from 0
to 100 was 90 (IQR 80–90) in children and 85
(IQR 70–95) in young adults (p 5 0.204). Ninety-
four percent of children and 83% of young adults
reported having enjoyed life in the week prior to
the follow-up assessment. Given the functional
impairment (mRS .1) in 44% of children and
45% of young adults, the overall good QoL is sur-
prising. However, when asked to rate their QoL in
comparison with presumed peers, almost one third of
both children and young adults estimated their QoL
as worse. These findings are in line with previous
studies.1,27,28 Compared with healthy controls, one
study found that the well-being of pediatric stroke
survivors was strongly affected, especially in patients
with moderate to severe disability.1 A further study
showed that QoL in children after AIS assessed with a
questionnaire adapted to their parents was excellent
in 36%, adequate in 45%, and poor in 19%.27
Another study revealed severe neurologic deficits,
impaired executive function, low self-esteem, and
poor family functioning, with resulting lower QoL
in all domains.28 Interestingly, in our study, 18% of
Table 3 Psychological and social outcome in stroke survivors
Characteristics
Children (n 5 82),
n with condition/
valid n (%)
Young adults
(n 5 143), n with
condition/valid n (%) p
Psychological outcome
Any psychological/psychiatric
disorders
12/82 (15) 27/143 (19) 0.466
Behavioral disturbances 11/82 (13) 7/139 (5) 0.040
Fatigue 11/82 (13) 25/143 (18) 0.452
Difficulty concentrating or
memory problems
8/82 (10) 15/139 (11) 1.00
Residence 0.584
At home, no special care 75/82 (92) 127/142 (89)
At home, needs more care than
expected
7/82 (8) 11/142 (8)
Nursing home 0/82 4/142 (3)
Schooling/occupation 0.348
Regular school/back to prior work 63/82 (77) 93/137 (68)
Special needs school/part-time,
retraining
16/82 (19) 29/137 (21)
Unable to read or work 3/82 (4) 15/137 (11)
Stroke impact on everyday life
Everyday life impaired in general 22/82 (27) 88/137 (64) ,0.001
Social life impaired 27/82 (33) 64/138 (46) 0.072
Dependent in social activities 12/82 (15) 10/139 (7) 0.104
Estimation of general state of health 0.418
Poor 0/82 3/136 (2)
Fair 3/82 (4) 14/136 (10)
Average 32/82 (39) 43/136 (32)
Good 32/82 (39) 54/136 (40)
Excellent 15/82 (18) 22/136 (16)
A 2-sided p value ,0.05 was considered statistically significant.
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children and 25% of young adults reported a better
QoL than their peers. Surviving a life-threating event
such as an AIS may increase the appreciation of life in
general, despite residual impairments.
The difference in long-term use of antithrombotic
medication reflects the fact that antithrombotic agents
are being used less often in children than in young
adults already in the acute phase after AIS.5 Moreover,
while antithrombotic secondary preventive treatment is
usually given lifelong to young adults after AIS, it is
withdrawn in some children with AIS, particularly when
associated with transient risk factors, such as acute infec-
tious diseases, if the etiology remained undetermined
and in absence of recurrent cerebrovascular events.
Our study has several limitations and some of
these have been addressed in our article on short-
term follow-up.5 In the present study, 18% of chil-
dren and young adults were lost to follow-up, for
reasons displayed in figure e-2. However, we applied
every possible way to trace our patients, but were
notably not allowed to have insight into death regis-
tries to assess whether patients have died. Further-
more, the median follow-up period was 6.9 years,
which makes complete follow-up less likely. We did
not find any differences in baseline characteristics in
patients with or without information on long-term
follow-up and rates of lost patients were equal in both
groups, which makes a selection bias unlikely.
Second, most follow-up interviews were per-
formed via telephone, which makes a physical
examination and standardized neuropsychological
testing impossible. Thus, we were unable to detect
subtle differences in cognitive outcome as noted by
our neuropsychological colleagues who reported that
children following AIS have a cognitive performance
that is lower than population norms in selective subt-
ests at 2 years after the event.4 However, given the
nationwide population-based registry, an additional
clinical study visit for long-term follow-up was
unfeasible.
Third, there is no scale validated for both children
and young adults to assess the impact of AIS on QoL.
We therefore had to assess QoL using nonvalidated
tools. However, functional outcomes in our study
were similar to other cohorts assessing outcome in
children and young adult cohorts. Thus, the relation
of outcomes in children to young adults in our study
may be generalized to comparable populations despite
the use of nonvalidated QoL measures.
Finally, follow-up interviews of children were
often performed with proxies, which was rarely the
case in young adults. This is a major shortcoming
when assessing outcome in children, since proxies
tend to overestimate sequelae. However, there were
no differences in obvious outcome measures such as
mortality, recurrence rates, and favorable outcome
(mRS 0–1), which can easily be defined both in chil-
dren and young adults.
This study shows no major differences in long-
term outcome after AIS in children and young adults.
AIS has a major impact not only in young adults but
also in children and is therefore not a benign condi-
tion that can easily be overcome by brain plasticity.
AUTHOR CONTRIBUTIONS
Dr. Barbara Goeggel Simonetti helped collect the data, performed the
analyses, and wrote the manuscript together with U.F. Ariane Cavelti col-
lected the data and revised the manuscript. Prof. Marcel Arnold planned
and supervised the study and revised the manuscript. Dr. Sandra Bigi
helped plan the study and collect the data and revised the manuscript.
Dr. Mária Regényi helped collect the data and revised the manuscript.
Prof. Heinrich P. Mattle helped collect the data and revised the manu-
script. Prof. Jan Gralla helped collect the data and revised the manuscript.
Dr. Joël Fluss helped collect the data and revised the manuscript. Prof.
Peter Weber helped collect the data and revised the manuscript.
Dr Annette Hackenberg helped collect the data and revised the manu-
script. Prof. Maja Steinlin planned and supervised the study, helped
collect the data, analyzed the data, and revised the manuscript. Prof.
Dr. Urs Fischer planned and supervised the study, helped collect the
data, analyzed the data, and wrote the manuscript together with B.G.S.
ACKNOWLEDGMENT
The authors thank Pietro Ballinari, PhD, for statistical advice, Laurie von
Melchner for linguistic advice, and Marianne Kormann, Andrea Surtmann
(study nurses), Edith Wehrli, Erik von Elm, and Julia Pavlovic (research
fellows) for help in collecting data.
STUDY FUNDING
The SNPSR is supported by grants from the Swiss Heart Foundation,
Novartis Research Foundation, Foundation for Research in Clinical
Neuropsychiatry, Müller Grocholsky Stiftung, and Batzenbär
Figure 2 Quality of life
Quality of life (QoL) rated on a continuous scale from 0 (very poor) to 100 (optimal) was as-
sessed in 82 (100%) surviving children and 137 (96%) young adults at long-term follow-up.
Median QoL was 90 (interquartile range [IQR] 80–90) in children and 85 (IQR 70–95) in
young adults (p 5 0.204). p 5 Mann-Whitney U test, 2-sided significance.
1946 Neurology 84 May 12, 2015
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Kinderkliniken Bern. None of the agencies that funded the Swiss Neuro-
pediatric Stroke Registry had any input into the design, performance,
analysis, or reporting of the registry or the present study or saw the
manuscript before submission.
DISCLOSURE
The authors report no disclosures relevant to the manuscript. Go to
Neurology.org for full disclosures.
Received July 3, 2014. Accepted in final form December 18, 2014.
REFERENCES
1. Neuner B, von Mackensen S, Krumpel A, et al. Health-
related quality of life in children and adolescents with
stroke, self-reports, and parent/proxies reports: cross-
sectional investigation. Ann Neurol 2011;70:70–78.
2. Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E,
Kirkham FJ. Outcome after ischaemic stroke in childhood.
Dev Med Child Neurol 2000;42:455–461.
3. Pavlovic J, Kaufmann F, Boltshauser E, et al. Neuropsycho-
logical problems after paediatric stroke: two year follow-up
of Swiss children. Neuropediatrics 2006;37:13–19.
4. Studer M, Boltshauser E, Capone Mori A, et al. Factors
affecting cognitive outcome in early pediatric stroke. Neu-
rology 2014;82:784–792.
5. Bigi S, Fischer U, Wehrli E, et al. Acute ischemic stroke in
children versus young adults. Ann Neurol 2011;70:
245–254.
6. De Schryver EL, Kappelle LJ, Jennekens-Schinkel A,
Boudewyn Peters AC. Prognosis of ischemic stroke in
childhood: a long-term follow-up study. Dev Med Child
Neurol 2000;42:313–318.
7. Steinlin M, Roellin K, Schroth G. Long-term follow-up
after stroke in childhood. Eur J Pediatr 2004;163:245–250.
8. Elbers J, Deveber G, Pontigon AM, Moharir M. Long-
term outcomes of pediatric ischemic stroke in adulthood.
J Child Neurol 2013;29:782–788.
9. Christerson S, Stromberg B. Stroke in Swedish children II:
long-term outcome. Acta Paediatr 2010;99:1650–1656.
10. Goldenberg NA, Bernard TJ, Fullerton HJ, Gordon A,
deVeber G; International Pediatric Stroke Study Group.
Antithrombotic treatments, outcomes, and prognostic fac-
tors in acute childhood-onset arterial ischaemic stroke: a
multicentre, observational, cohort study. Lancet Neurol
2009;8:1120–1127.
11. Kappelle LJ, Adams HP Jr, Heffner ML, Torner JC,
Gomez F, Biller J. Prognosis of young adults with ischemic
stroke: a long-term follow-up study assessing recurrent vas-
cular events and functional outcome in the Iowa Registry of
Stroke in Young Adults. Stroke 1994;25:1360–1365.
12. Leys D, Bandu L, Henon H, et al. Clinical outcome in
287 consecutive young adults (15 to 45 years) with ische-
mic stroke. Neurology 2002;59:26–33.
13. Neau JP, Ingrand P, Mouille-Brachet C, et al. Functional
recovery and social outcome after cerebral infarction in
young adults. Cerebrovasc Dis 1998;8:296–302.
14. Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischae-
mic stroke in young adults: predictors of outcome and
recurrence. J Neurol Neurosurg Psychiatry 2005;76:
191–195.
15. Rutten-Jacobs LC, Maaijwee NA, Arntz RM, et al.
Long-term risk of recurrent vascular events after
young stroke: the FUTURE study. Ann Neurol 2013;
74:592–601.
16. Strater R, Becker S, von Eckardstein A, et al. Prospective
assessment of risk factors for recurrent stroke during
childhood–a 5-year follow-up study. Lancet 2002;360:
1540–1545.
17. Chabrier S, Husson B, Lasjaunias P, Landrieu P,
Tardieu M. Stroke in childhood: outcome and recurrence
risk by mechanism in 59 patients. J Child Neurol 2000;
15:290–294.
18. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical
and radiological recurrence after childhood arterial ische-
mic stroke. Circulation 2006;114:2170–2177.
19. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of
recurrent childhood arterial ischemic stroke in a
population-based cohort: the importance of cerebrovascu-
lar imaging. Pediatrics 2007;119:495–501.
20. Holland SK, Plante E, Weber Byars A, Strawsburg RH,
Schmithorst VJ, Ball WS Jr. Normal fMRI brain activa-
tion patterns in children performing a verb generation
task. Neuroimage 2001;14:837–843.
21. Szaflarski JP, Schmithorst VJ, Altaye M, et al. A longitu-
dinal functional magnetic resonance imaging study of lan-
guage development in children 5 to 11 years old. Ann
Neurol 2006;59:796–807.
22. Everts R, Lidzba K, Wilke M, et al. Lateralization of cog-
nitive functions after stroke in childhood. Brain Inj 2010;
24:859–870.
23. Long B, Spencer-Smith MM, Jacobs R, et al. Executive
function following child stroke: the impact of lesion loca-
tion. J Child Neurol 2011;26:279–287.
24. Waje-Andreassen U, Thomassen L, Jusufovic M, et al.
Ischaemic stroke at a young age is a serious event: final
results of a population-based long-term follow-up in West-
ern Norway. Eur J Neurol 2013;20:818–823.
25. Synhaeve NE, Arntz RM, Maaijwee NA, et al. Poor long-
term functional outcome after stroke among adults aged
18 to 50 years: Follow-Up of Transient Ischemic Attack
and Stroke Patients and Unelucidated Risk Factor Evalu-
ation (FUTURE) study. Stroke 2014;45:1157–1160.
26. Gomes A, Rinehart N, Greenham M, Anderson V. A crit-
ical review of psychosocial outcomes following childhood
stroke (1995–2012). Dev Neuropsychol 2014;39:9–24.
27. Friefeld SJ, Westmacott R, Macgregor D, Deveber GA.
Predictors of quality of life in pediatric survivors of arterial
ischemic stroke and cerebral sinovenous thrombosis.
J Child Neurol 2011;26:1186–1192.
28. O’Keeffe F, Ganesan V, King J, Murphy T. Quality-of-life
and psychosocial outcome following childhood arterial
ischaemic stroke. Brain Inj 2012;26:1072–1083.
Neurology 84 May 12, 2015 1947
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
DOI 10.1212/WNL.0000000000001555
2015;84;1941-1947 Published Online before print April 10, 2015Neurology 
Barbara Goeggel Simonetti, Ariane Cavelti, Marcel Arnold, et al. 
Long-term outcome after arterial ischemic stroke in children and young adults
This information is current as of April 10, 2015
rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.
1951, it is now a weekly with 48 issues per year. Copyright © 2015 American Academy of Neurology. All 
® is the official journal of the American Academy of Neurology. Published continuously sinceNeurology 
Services
Updated Information &
 http://www.neurology.org/content/84/19/1941.full.html
including high resolution figures, can be found at:
Supplementary Material
 001555.DC2.html
http://www.neurology.org/content/suppl/2015/04/10/WNL.0000000000
 001555.DC1.html
http://www.neurology.org/content/suppl/2015/04/10/WNL.0000000000
Supplementary material can be found at: 
References
 http://www.neurology.org/content/84/19/1941.full.html##ref-list-1
This article cites 28 articles, 10 of which you can access for free at: 
Citations
 http://www.neurology.org/content/84/19/1941.full.html##otherarticles
This article has been cited by 1 HighWire-hosted articles: 
Subspecialty Collections
 http://www.neurology.org//cgi/collection/stroke_in_young_adults
Stroke in young adults
 http://www.neurology.org//cgi/collection/prognosis
Prognosis
 vascular_disease-childhood_stroke
http://www.neurology.org//cgi/collection/pediatric_stroke_see_cerebro
Pediatric stroke; see Cerebrovascular Disease/ Childhood stroke
 http://www.neurology.org//cgi/collection/childhood_stroke
Childhood stroke
 stroke
http://www.neurology.org//cgi/collection/all_cerebrovascular_disease_
All Cerebrovascular disease/Stroke
following collection(s): 
This article, along with others on similar topics, appears in the
  
Permissions & Licensing
 http://www.neurology.org/misc/about.xhtml#permissions
its entirety can be found online at:
Information about reproducing this article in parts (figures,tables) or in
  
Reprints
 http://www.neurology.org/misc/addir.xhtml#reprintsus
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.
1951, it is now a weekly with 48 issues per year. Copyright © 2015 American Academy of Neurology. All 
® is the official journal of the American Academy of Neurology. Published continuously sinceNeurology 
